Globus Medical Inc Class A (GMED)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$85.65

Buy

$89.00

arrow-down$-2.18 (-2.45%)

Prices updated at 13 Dec 2025, 00:55 EST

Prices minimum 15 mins delay

Prices in USD

Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. David C. Paul

CEO

Mr. Keith W. Pfeil

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

5,300

Head office

2560 General Armistead Avenue

Audubon

United States

19403

+1 610 930-1800

investors@globusmedical.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Keith W. Pfeil Director, President, Chief Executive Officer and Chief Operating Officer	0.46m
Mr. Kyle Kline Chief Financial Officer and Principal Accounting Officer	-
Mr. James R. Tobin Independent Director	0.09m
Dr. John A. DeFord, PhD Independent Director	0.08m
Mr. Robert Andrew Douglas Independent Director	0.08m
Mr. Stephen T. Zarrilli Independent Director	0.08m
Ms. Ann D. Rhoads Independent Director	0.11m
Mr. Daniel T. Lemaitre Independent Director	0.09m
Ms. Leslie V. Norwalk, Esq. Independent Director	0.08m
Mr. David D. Davidar Independent Director	0.09m
Mr. David C. Paul Executive Chairman of the Board	0.46m
Mr. Daniel J. Wolterman Independent Director	0.08m
Ms. Kelly G. Huller Executive Vice President, General Counsel and Corporate Secretary	0.36m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	10,708,893
BlackRock Inc	10,533,319
HHG PLC	7,552,637
JPMorgan Chase & Co	7,363,914
BlackRock Fund Advisors	6,155,684

Director dealings

Date chevron-l-regular chevron-r-regular	Action
02 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
21 Nov 2024	-
21 Nov 2024	-
22 Nov 2024	-
22 Nov 2024	-
21 Nov 2024	-
22 Nov 2024	-
22 Nov 2024	-
22 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.